Aidan Pursley

ScholarGPS® ID: 15626272037625

Affiliation
University of Virginia, Charlottesville, United States
Affiliation History

Field
Medicine
Discipline
Hematology
Metrics Summary
Publication Count
4
Predicted Citations
0
Predicted h-index
0
Ranking

Publications and Citation History

Publications based on Top Specialties

Types of Publication

  • Publications
  • Books
  • Patents
  • NIH/NSF
You must register and claim your profile to add or remove publications from it.
... publications
FILTER BY:
Year
Type
Specialty
Affiliations
Access
Co-Authors
Add
Delete
Tolinapant, a Non-Peptidomimetic Antagonist of Inhibitors of Apoptosis Proteins, cIAP1/2 and XIAP, in Combination with the Hypomethylating Agents, Azacytidine and Decitabine Are Highly Synergistic in in Vitro Models of T Cell Lymphoma (journal article)
Manavalan, John Sanil | Pal, Ipsita | Pursley, Aidan | Ward, George A. | Smyth, Tomoko | Sims, Martin | Taylor, Jason A. | Feith, David J | Loughran, Thomas P. | O'Connor, Owen A. | Marchi, Enrica
Blood, volume 140, issue Supplement 1, pages 11552-11553 (2022).
10.1182/blood-2022-169906
Cite | Source
The combination of the IAP antagonist, tolinapant and hypomethylating agents (HMA) is highly synergistic in in vitro models of T-cell lymphoma (TCL). (journal article)
Manavalan, John | Pal, Ipsita | Pursley, Aidan | Ward, George | Smyth, Tomoko | Sims, Martin | Feith, David | Loughran, Thomas | O’Connor, Owen | Marchi, Enrica
Journal of Clinical Oncology, volume 40, issue 16_suppl, pages e15088-e15088 (2022).
10.1200/JCO.2022.40.16_suppl.e15088
Cite | Source
P1278: ACTIVATION OF THE NECROPTOSIS PATHWAY PLAYS A ROLE IN SYNERGISM WITH COMBINATION OF THE IAP ANTAGONIST, TOLINAPANT AND HYPOMETHYLATING AGENTS (HMA) IN IN VITRO MODELS OF T-CELL LYMPHOMA (TCL). (journal article)
Manavalan, J. S. | Pal, I. | Pursley, A. | Ward, G. | Smyth, T. | Sims, M. | Feith, D. | Loughran, T. P. | O’Connor, O. A. | Marchi, E.
HemaSphere, volume 6 (2022).
10.1097/01.HS9.0000847976.26425.20
Cite | Source
Tolinapant (ASTX660), a Non-Peptidomimetic Antagonist of cIAP1/2 and XIAP, and the HDAC Inhibitor Romidepsin Are Synergistic in in Vitro Models of T Cell Lymphoma (journal article)
Manavalan, John S | Pal, Ipsita | Pursley, Aidan | Ward, George A. | Smyth, Tomoko | Sims, Martin | Feith, David J | Loughran, Thomas P. | O'Connor, Owen A. | Marchi, Enrica
Blood, volume 138, issue Supplement 1, pages 4356-4356 (2021).
10.1182/blood-2021-153451
Cite | Source